Gaxosai INC

Gaxos.ai Inc. has sold its gaming assets and Gaxos Gaming Labs to Game Foundry AI for approximately $1.76 million in stock to streamline operations.

Gaxos.ai Inc. increased the maximum aggregate offering price under its At The Market offering agreement by an additional $1,065,001, following approximately $5.6 million in prior sales.

Gaxos.ai Inc. has increased its At The Market offering capacity by an additional $2.6 million, bringing the total potential raise to $5.6 million.

Gaxos.ai Inc. has entered into an At The Market Offering Agreement to sell up to $3 million of common stock, enhancing its capital raising flexibility.

Gaxos.ai Inc. announced the successful election of all director nominees, ratification of its independent auditor, and approval of an amendment to its equity incentive plan at its 2025 annual meeting.

Gaxos.ai Inc. announces its reincorporation from Delaware to Nevada, effective March 3, 2025, following stockholder approval.

Gaxos.AI Inc. reported a significant increase in revenue for the first quarter of 2026, driven by its RNK Health and Gaxos Labs subscription services, though net loss also widened due to increased operating expenses.

Gaxos.AI reported a significant revenue increase in Q3 2025 driven by its RNK Health and subscription services, though net losses also expanded due to higher operating expenses.

Gaxos.AI Inc. reported a significant increase in revenue driven by new AI initiatives in gaming and health, though net losses also widened as the company continues heavy investment in development.

Gaxos.ai Inc. reports increased revenue for Q1 2025, driven primarily by its RNK Health subsidiary, while continuing to invest in AI-powered health and gaming solutions.

Gaxos.ai Inc. reported its financial results for the third quarter of 2024, highlighting revenue generation from its new Gaxos Health initiative and a decrease in operating expenses.

Gaxos.ai Inc. reported its financial results for the quarter ended June 30, 2024, highlighting ongoing investments in AI-driven gaming and health platforms.

Gaxos.AI experienced a significant revenue surge in 2025 driven by new AI product launches and health services, yet reported a wider net loss as operating expenses, particularly marketing, escalated.

Gaxos.ai Inc. files its 10-K, highlighting its AI-driven initiatives in health and entertainment despite incurring operating losses and focusing on future revenue generation.

Gaxos.ai Inc.'s 10-K filing outlines its share structure, development of AI-driven gaming and health platforms, and financial status as of December 31, 2023.

GAXOS.AI Inc. Director Scott Grayson was granted 25,000 employee stock options at an exercise price of $1.32, vesting in one year.

GAXOS.AI Director Roman Feldman was granted 25,000 employee stock options with an exercise price of $1.32, vesting on March 20, 2027.

GAXOS.AI Director and 10% owner Adam Holzer was granted 25,000 employee stock options with an exercise price of $1.32, vesting in one year.

Director Adam Holzer reports acquisition of stock options in GAXOS.AI INC.

Director Grayson Scott acquired 25,000 employee stock options in GAXOS.AI INC. on April 14, 2025, according to a Form 4 filing.

Director Roman Feldman reports acquisition of 25,000 employee stock options in GAXOS.AI INC.

Gaxos.ai Inc. announces its 2026 Annual Meeting of Shareholders, detailing proposals including director elections, auditor ratification, equity plan amendment, and a potential reverse stock split.

GAXOS.AI INC. has filed a Definitive Proxy Statement (Schedule 14A) with the U.S. Securities and Exchange Commission.

Gaxos.ai Inc. has announced its 2025 Annual Meeting of Shareholders, where key proposals include the election of directors, auditor ratification, and a substantial increase in shares reserved for its equity incentive plan.

Gaxos.ai Inc. is seeking stockholder approval for a share decrease and reincorporation from Delaware to Nevada at its upcoming annual meeting on December 27, 2024.

Gaxos.ai Inc. has filed an amendment to its registration statement for the resale of up to 3,005,642 shares of common stock by selling stockholders, primarily derived from the exercise of warrants.

Gaxos.ai Inc. has filed a registration statement for the resale of up to 3,005,642 shares of its common stock by selling stockholders, potentially generating $9.7 million in gross proceeds for the company upon cash exercise of warrants.

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a 4.9% beneficial ownership stake in Gaxos.ai Inc. common stock, primarily through warrants.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed a Schedule 13G disclosing a passive beneficial ownership of 4.99% in Gaxos.ai Inc. common stock, limited by a warrant blocker provision.